JP2017531659A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017531659A5 JP2017531659A5 JP2017518466A JP2017518466A JP2017531659A5 JP 2017531659 A5 JP2017531659 A5 JP 2017531659A5 JP 2017518466 A JP2017518466 A JP 2017518466A JP 2017518466 A JP2017518466 A JP 2017518466A JP 2017531659 A5 JP2017531659 A5 JP 2017531659A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- factor
- composition according
- colloidal particles
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1417589.7 | 2014-10-06 | ||
| GBGB1417589.7A GB201417589D0 (en) | 2014-10-06 | 2014-10-06 | Pharmaceutical Formulations |
| PCT/EP2015/073003 WO2016055447A1 (en) | 2014-10-06 | 2015-10-06 | Pharmaceutical formulations of pegylated liposomes and blood coagulation factors |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020129101A Division JP2020183446A (ja) | 2014-10-06 | 2020-07-30 | Ｐｅｇ化リポソームおよび血液凝固因子の製剤処方 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2017531659A JP2017531659A (ja) | 2017-10-26 |
| JP2017531659A5 true JP2017531659A5 (cg-RX-API-DMAC10.html) | 2018-11-15 |
Family
ID=51946871
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017518466A Pending JP2017531659A (ja) | 2014-10-06 | 2015-10-06 | Ｐｅｇ化リポソームおよび血液凝固因子の製剤処方 |
| JP2020129101A Pending JP2020183446A (ja) | 2014-10-06 | 2020-07-30 | Ｐｅｇ化リポソームおよび血液凝固因子の製剤処方 |
| JP2022168146A Active JP7573582B2 (ja) | 2014-10-06 | 2022-10-20 | Ｐｅｇ化リポソームおよび血液凝固因子の製剤処方 |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020129101A Pending JP2020183446A (ja) | 2014-10-06 | 2020-07-30 | Ｐｅｇ化リポソームおよび血液凝固因子の製剤処方 |
| JP2022168146A Active JP7573582B2 (ja) | 2014-10-06 | 2022-10-20 | Ｐｅｇ化リポソームおよび血液凝固因子の製剤処方 |
Country Status (17)
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201417589D0 (en) * | 2014-10-06 | 2014-11-19 | Cantab Biopharmaceuticals Patents Ltd | Pharmaceutical Formulations |
| WO2017204896A1 (en) * | 2016-05-26 | 2017-11-30 | Becton, Dickinson And Company | Methods and devices for liposome preparation by centrifugation |
| GB202111757D0 (en) * | 2021-08-17 | 2021-09-29 | Cantab Biopharmaceuticals Patents Ltd | Modified colloidal particles for use in the treatment of haemophilia A |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5013556A (en) | 1989-10-20 | 1991-05-07 | Liposome Technology, Inc. | Liposomes with enhanced circulation time |
| US6326353B1 (en) | 1993-03-23 | 2001-12-04 | Sequus Pharmaceuticals, Inc. | Enhanced circulation effector composition and method |
| AU7384994A (en) | 1993-08-06 | 1995-02-28 | Opperbas Holding B.V. | A method for high loading of vesicles with biopolymeric substances |
| IL113010A0 (en) * | 1994-03-31 | 1995-10-31 | Pharmacia Ab | Pharmaceutical formulation comprising factor VIII or factor ix with an activity of at least 200 IU/ml and an enhancer for improved subcutaneous intramuscular or intradermal administration |
| US6156337A (en) * | 1994-07-08 | 2000-12-05 | Opperbas Holding B.V. | Method for high loading of vesicles with biopolymeric substances |
| US6310183B1 (en) * | 1997-09-10 | 2001-10-30 | Novo Nordisk A/S | Coagulation factor VIIa composition |
| CA2329768C (en) * | 1998-04-27 | 2008-06-10 | Opperbas Holding B.V. | Pharmaceutical composition comprising factor viii and neutral liposomes |
| PT1198490E (pt) * | 1999-07-14 | 2006-06-30 | Alza Corp | Lipopolimeros neutros e composicoes liposomais que contem os mesmos |
| JP5090605B2 (ja) * | 2000-05-03 | 2012-12-05 | ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト | 凝固因子ｖｉｉの皮下投与 |
| US20030232075A1 (en) | 2002-05-06 | 2003-12-18 | University Of Minnesota, A Minnesota Corporation | Compositions for producing factor Xa |
| PT1633440E (pt) | 2003-04-15 | 2008-08-25 | Opperbas Holding Bv | Composição farmacêutica que compreende proteínas e/ou polipéptidos e partículas coloidais |
| BRPI0612843A2 (pt) * | 2005-06-29 | 2010-11-30 | The Research Foundation Of State University Of New York | composição farmacêutica, métodos para fabricar a composição, e, uso de uma formulação |
| JP5558106B2 (ja) * | 2007-01-03 | 2014-07-23 | ノボ ノルディスク ヘルス ケア アーゲー | 凝固第ｖｉｉ因子関連ポリペプチドの皮下投与 |
| US20090117087A1 (en) | 2007-04-13 | 2009-05-07 | Wake Forest University | Methods and compositions for printing biologically compatible nanotube composites of autologous tissue |
| JP2012528846A (ja) | 2009-06-03 | 2012-11-15 | マヨ、ジョン、チャールズ | 深部組織の痛みを治療するための製剤 |
| GB2486371A (en) | 2009-08-21 | 2012-06-13 | Targeted Delivery Technologies Ltd | Vesicular formulations |
| GB201007356D0 (en) | 2010-04-30 | 2010-06-16 | Leverton Licence Holdings Ltd | Conjugated factor VIIa |
| GB201007357D0 (en) | 2010-04-30 | 2010-06-16 | Leverton Licence Holdings Ltd | Conjugated factor VIII |
| AR082803A1 (es) * | 2010-09-01 | 2013-01-09 | Portola Pharm Inc | Metodos y formulaciones para el tratamiento de la trombosis con betrixaban y un inhibidor de la glicoproteina p |
| HK1200695A1 (en) * | 2012-04-16 | 2015-08-14 | Cantab Biopharmaceuticals Patents Limited | Optimised subcutaneous therapeutic agents |
| GB201417589D0 (en) * | 2014-10-06 | 2014-11-19 | Cantab Biopharmaceuticals Patents Ltd | Pharmaceutical Formulations |
-
2014
- 2014-10-06 GB GBGB1417589.7A patent/GB201417589D0/en not_active Ceased
-
2015
- 2015-10-06 HU HUE15775444A patent/HUE063656T2/hu unknown
- 2015-10-06 BR BR112017007031A patent/BR112017007031A2/pt active Search and Examination
- 2015-10-06 WO PCT/EP2015/073003 patent/WO2016055447A1/en not_active Ceased
- 2015-10-06 AU AU2015330102A patent/AU2015330102B2/en not_active Ceased
- 2015-10-06 HR HRP20230985TT patent/HRP20230985T1/hr unknown
- 2015-10-06 SM SM20230271T patent/SMT202300271T1/it unknown
- 2015-10-06 ES ES15775444T patent/ES2954134T3/es active Active
- 2015-10-06 PL PL15775444.1T patent/PL3204034T3/pl unknown
- 2015-10-06 US US15/517,148 patent/US20170304203A1/en not_active Abandoned
- 2015-10-06 JP JP2017518466A patent/JP2017531659A/ja active Pending
- 2015-10-06 CA CA2994891A patent/CA2994891C/en active Active
- 2015-10-06 RU RU2017115831A patent/RU2737291C2/ru active
- 2015-10-06 MX MX2017004378A patent/MX384517B/es unknown
- 2015-10-06 EP EP15775444.1A patent/EP3204034B9/en active Active
- 2015-10-06 RS RS20230695A patent/RS64461B1/sr unknown
-
2018
- 2018-08-01 US US16/052,300 patent/US11484499B2/en active Active
-
2020
- 2020-07-30 JP JP2020129101A patent/JP2020183446A/ja active Pending
-
2022
- 2022-10-20 JP JP2022168146A patent/JP7573582B2/ja active Active
-
2023
- 2023-09-06 CY CY20231100471T patent/CY1126253T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Montazerian et al. | Engineered hemostatic biomaterials for sealing wounds | |
| Yu et al. | Stimulus‐responsive hydrogels as drug delivery systems for inflammation targeted therapy | |
| JP6408469B2 (ja) | ヒアルロン酸をベースとする薬物送達システム | |
| Dong et al. | Injectable adhesive hydrogel through a microcapsule cross-link for periodontitis treatment | |
| CN103687631B (zh) | 促凝血肽及其衍生物以及它们的用途 | |
| JP2020073617A (ja) | 免疫療法のための調節粒子 | |
| WO2023231051A1 (zh) | 一种用于治疗糖尿病创面的抗菌抗氧化水凝胶敷料及其制备方法 | |
| JP2014533988A5 (cg-RX-API-DMAC10.html) | ||
| JP2002512947A5 (cg-RX-API-DMAC10.html) | ||
| JP2012025955A5 (cg-RX-API-DMAC10.html) | ||
| Chan et al. | Synthetic strategies for engineering intravenous hemostats | |
| CN107027292A (zh) | 均匀膜组合物 | |
| TW201737925A (zh) | 對於防止黏連或止血有用之醫藥組成物 | |
| CN103189078A (zh) | 含有透明质酸和l-精氨酸的抗粘连剂 | |
| CN103877621B (zh) | 一种电纺纤维增强磷酸钙骨水泥复合材料及其应用 | |
| Joo et al. | Fibrinogen as a promising material for various biomedical applications | |
| Liu et al. | Recent advances in topical hemostatic materials | |
| Guo et al. | Periodontium-mimicking, multifunctional biomass-based hydrogel promotes full-course socket healing | |
| Teng et al. | Biomimetic and wound microenvironment-modulating PEGylated glycopolypeptide hydrogels for arterial massive hemorrhage and wound prohealing | |
| JP2018535952A5 (cg-RX-API-DMAC10.html) | ||
| RU2017115831A (ru) | Фармацевтические составы пегилированных липосом и факторов свертывания крови | |
| ES2657901T3 (es) | Utilidad ampliada de las micropartículas derivadas de glóbulos rojos (RMP) para el tratamiento de la hemorragia | |
| JP5889188B2 (ja) | 組織接着用シート製剤 | |
| KR20160118624A (ko) | 유착 방지제 | |
| Benedini et al. | Nanodevices for facing new challenges of medical treatments: Stimuli-responsive drug delivery systems |